Cinnamon leaf

Drug interactions. May inhibit blood clotting. May contain safrole. Moderate risk of skin sensitization. Low risk of mucous membrane irritation.

Oral: pethidine, MAOIs, SSRIs, anticoagulant medication, before major surgery, peptic ulcer, hemophilia.

Maximum adult oral dose 175 mg daily.

Maximum dermal use level 0.6 percent based on 87 percent eugenol and a dermal limit of 0.5 percent.

Cinnamon leaf oil contains more eugenol than cinnamaldehyde, distinct safety profile from cinnamon bark.

Occupational ACD has been reported, some through airborne contact.

Same tree as cinnamon bark, Cinnamomum verum, but the oil is distilled from leaves. Eugenol content is 4 to 8 times higher than bark oil.

Leaf oil is significantly cheaper than bark. In perfumery, leaf oil is often blended in as a substitute for bark when cost-reducing.

Family Lauraceae.

May be adulterated by addition of clove fractions, eugenol or cinnamic aldehyde.